癌症老年患者共发病的预后价值:ELCAPA队列研究
M-A Benderra1, A G Serrano2, E Paillaud3
1Université Paris-Est Créteil, INSERM, IMRB, Créteil, France; AP-HP, Henri-Mondor Hospital, Public Health Department & Clinical Research Unit (URC Mondor), Créteil, France; Institut Universitaire de Cancérologie (IUC), AP-HP, Sorbonne Université, Paris, France; Department of Medical Oncology, AP-HP, Tenon Hospital, Paris, France.
ESMO open
|October 13, 2023
概括
在老年癌症患者中,并发症显著影响存活率. 较高的累积疾病评分表-老年病学 (CIRS-G) 评分表明死亡风险增加,这表明其在临床实践中的使用.
科学领域:
- 老年瘤学 老年瘤学
- 临床流行病学临床流行病学
背景情况:
- 伴随性疾病在老年癌症患者中具有显著的死亡风险,通常与癌症本身竞争.
- 评估并发症的预后价值对于了解这一群体的生存结果至关重要.
研究的目的:
- 评估老年患者诊断出常见癌症的并发症的预后意义.
- 确定并发症负担与整体存活率 (OS) 之间的关联.
主要方法:
- 分析了来自ELCAPA队列的1551名70岁以上患有结直肠,乳腺,前列腺或肺癌的患者.
- 使用累积疾病评分表-老年病学 (CIRS-G) 评分来评估并发症.
- 3,12和36个月的整体存活率 (OS) 是主要终点,用于分析的限制平均存活时间 (RMST).
主要成果:
- 超过17的CIRS-G得分,多种严重并发症的存在,或超过7种并发症独立地与减少的OS有关.
- 特定的并发症,如心力衰竭和认知障碍,也与较短的存活率有关.
- 在36个月内,CIRS-G得分>17显示调整后的RMST在所有研究的癌症类型中显著减少.
结论:
- 伴随性疾病的类型,数量和严重程度独立地与老年癌症患者的整体存活率下降有关.
- 56分之17的CIRS-G分数切断值可能是临床实践中预测生存结果的宝贵工具.
相关概念视频
Cancer Survival Analysis
359
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
359
Psychoneuroimmunology: Diabetes and Cancer
35
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
35
Comparing the Survival Analysis of Two or More Groups
202
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
202
Kaplan-Meier Approach
155
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
155
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
COPD: Pathogenesis and Clinical Features
309
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
309


